Acute and Chronic Disease Reports
Open Access

Cardiac Failure: Treatment Strategies and Supportive Care

John Apro^{* *}Correspondence: John Apro, Department of Cardiology, University College London, London, UK, Email:

Author info »

Description

Cardiac failure, also known as heart failure, is a complex medical condition that requires careful management to enhance quality of life and prolong survival. It occurs when the heart is unable to pump blood efficiently that is enough to meet the body needs [1].

Lifestyle modifications

The lifestyle modifications include;

Dietary changes: A heart-healthy diet of low in sodium and saturated fats is important for managing cardiac failure. This involves reducing salt intake to prevent fluid retention and managing portion sizes to maintain a healthy weight. A diet rich in fruits, vegetables, whole grains and lean proteins can support overall heart health.

Fluid restriction: Limiting fluid intake may be necessary for patients with severe cardiac failure to prevent fluid overload, which can increase symptoms such as shortness of breath and edema (swelling).

Exercise: Regular physical activity is beneficial for strengthening the heart muscle and improving cardiovascular fitness. Exercise programs should be supervised and adjusted based on the patient's condition and functional capacity.

Smoking cessation: Quitting smoking is essential for managing cardiac failure as smoking can worsen cardiovascular health and increase the risk of complications.

Alcohol limitation: Limiting alcohol consumption is recommended as excessive alcohol intake can weaken the heart muscle and contribute to heart failure progression [2].

Medications

Diuretics, such as furosemide and spironolactone, are commonly prescribed to reduce fluid retention and alleviate symptoms of congestion in cardiac failure patients. Angiotensin-Converting Enzyme (ACE) inhibitors and Angiotensin II Receptor Blockers (ARBs) are the medications which help to relax blood vessels, lower blood pressure and reduce the workload on the heart.

They are important in managing cardiac failure caused by hypertension and other conditions [3].

Beta-blockers, like carvedilol and metoprolol, slow the heart rate and decrease the heart's workload, improving symptoms and reducing the risk of disease progression. Aldosterone antagonist drugs such as spironolactone and eplerenone block the effects of aldosterone, a hormone that can contribute to fluid retention and heart damage. In some cases, digoxin may be prescribed to strengthen heart contractions and regulate heart rhythm. Patients with cardiac failure may require anticoagulant therapy to reduce the risk of blood clots, particularly if atrial fibrillation (an irregular heart rhythm) is present [4].

Devices and surgical interventions

Devices and surgical interventions includes;

Implantable Cardioverter-Defibrillator (ICD): An ICD is a device implanted under the skin to monitor heart rhythm. It delivers an electric shock to restore normal rhythm if a life-threatening arrhythmia occurs.

Cardiac Resynchronization Therapy (CRT): CRT involves implanting a special pacemaker that coordinates the contractions of the heart ventricles, improving pumping efficiency in certain types of cardiac failure.

Ventricular Assist Devices (VADs): VADs are mechanical pumps implanted in the chest or abdomen to help the heart pump blood to the rest of the body. They are used as a connection to heart transplantation or as destination therapy in patients who are not undergoing transplant [5,6].

Lifestyle and emotional support

Lifestyle and emotional support include cardiac rehabilitation and psychological support.

Cardiac rehabilitation: Comprehensive programs that include exercise training, education and psychological support can help patients recover from cardiac events and manage chronic cardiac failure effectively.

Psychological support: Living with cardiac failure can be challenging emotionally and psychologically. Counseling and support groups can provide patients and their families with the tools and encouragement needed to cope with the condition [7-10].

Monitoring and follow-up

Regular monitoring of symptoms, cardiac function and medication effectiveness is essential for managing cardiac failure. Adjustments to treatment plans may be necessary based on changes in the patient's condition and response to therapy.

Conclusion

The treatment of cardiac failure requires a multi-faceted approach that includes lifestyle modifications, medications, devices and surgical interventions. Treatment to individual patient needs, monitoring closely for complications and providing ongoing support are key to optimizing outcomes and improving quality of life for patients living with this chronic condition. By implementing comprehensive treatment strategies and promoting patient adherence to therapy, healthcare providers can effectively manage cardiac failure and mitigate its impact on patients' lives.

References

1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421.

   [Crossref] [Google Scholar] [PubMed]

2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(48):4901.

   [Crossref] [Google Scholar] [PubMed]

3. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365(9474):1877-1889.

   [Crossref] [PubMed]

4. Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJ, et al. Exercise‐based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev. 2019(1):CD003331.

   [Crossref] [Google Scholar] [PubMed]

5. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes III NM, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the heart rhythm society. Circulation. 2012;126(14):1784-1800.

   [Crossref] [Google Scholar] [PubMed]

6. Kuck KH, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, et al. New devices in heart failure: An European Heart Rhythm Association report: Developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2014;16(1):109-128.

   [Crossref] [Google Scholar] [PubMed]

7. Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981-1995.

   [Crossref]

8. Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, et al. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013;6(2):171-177.

   [Crossref] [Google Scholar] [PubMed]

9. Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, et al. Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Fail. 2018;6(4):273-285.

   [Crossref] [Google Scholar] [PubMed]

10. Mehta PK, Wei J, Wenger NK. Ischemic heart disease in women: A focus on risk factors. Trends Cardiovasc Med. 2015;25(2):140-151.

    [Crossref] [Google Scholar] [PubMed]